New and old GFR equations: a European perspective
Clinical Kidney Journal · 31.08.2023 · 16 (9) · 1375-1383
DOI: 10.1093/ckj/sfad039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Kidney Journal, online erschienen am 15.03.2023. Verfasst von Pierre Delanaye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Glomerular filtration rate (GFR) is estimated in clinical practice from equations based on the serum concentration of endogenous biomarkers and demographic data. The 2009 creatinine-based Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI2009) was recommended worldwide until 2021, when it was recalibrated to remove the African-American race factor. The CKD-EPI2009 and CKD-EPIcr2021 equations overestimate GFR of adults aged 18–30 years, with a strong overestimation in estimated GFR (eGFR) at age 18 years. CKD-EPICr2021 does not perform better than CKD-EPI2009 in US population, overestimating GFR in non-Black subjects, and underestimating it in Black subjects with the same magnitude. CKD-EPICr2021 performed worse than the CKD-EPI2009 in White Europeans, and provides no or limited performance gains in Black European and Black African populations. The European Kidney Function Consortium (EKFC) equation, which incorporates median normal value of serum creatinine in healthy population, overcomes the limitations of the CKD-EPI equations: it provides a continuity of eGFR at the transition between pediatric and adult care, and performs reasonably well in diverse populations, assuming dedicated scaling of serum creatinine (Q) values is used. The new EKFC equation based on cystatin C (EKFCCC) shares the same mathematical construction, namely, it incorporates the median cystatin C value in the general population, which is independent of sex and ethnicity. EKFCCC is therefore a sex-free and race-free equation, which performs better than the CKD-EPI equation based on cystatin C. Despite advances in the field of GFR estimation, no equation is perfectly accurate, and GFR measurement by exogenous tracer clearance is still required in specific populations and/or specific clinical situations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium.
- Department of Nephrology-Dialysis-Apheresis, Hôpital Universitaire Carémeau, Nîmes, France.
- Department of Clinical Chemistry, University of Liège, CHU Sart Tilman, Liège, Belgium.
- Department of Public Health and Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
- Université Paris Est Créteil, INSERM, Institut Mondor de Recherche Biomédicale (IMRB), Créteil, France.
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Service de Néphrologie et Transplantation, Fédération Hospitalo-Universitaire « Innovative therapy for immune disorders », Créteil, France.
ORCID-Profile: Pierre Delanaye, Etienne Cavalier, Thomas Stehlé
Zitieren
APA
Delanaye, P., Cavalier, E., Pottel, H., & Stehlé, T. (2023). New and old GFR equations: a European perspective. Clinical Kidney Journal, 16(9), 1375-1383. https://doi.org/10.1093/ckj/sfad039
Vancouver
Delanaye P, Cavalier E, Pottel H, Stehlé T. New and old GFR equations: a European perspective. Clinical Kidney Journal. 2023;16(9):1375-1383. doi:10.1093/ckj/sfad039
BibTeX
@article{Delanaye2023,
author = {Delanaye, Pierre and Cavalier, Etienne and Pottel, Hans and Stehlé, Thomas},
title = {New and old GFR equations: a European perspective},
journal = {Clinical Kidney Journal},
year = {2023},
volume = {16},
number = {9},
pages = {1375--1383},
doi = {10.1093/ckj/sfad039}
}
EUVIMED